Migraines? A Local Clinical Trial May Be for You

Print icon

The Hartford HealthCare Headache Center is currently conducting a research study of a home treatment for migraine using self-administered investigational medical device.

The study device is non-invasive and does not require medications intake. Compensation for your time and travel is available. Hartford HealthCare Headache Center medical director Dr. Brian Grosberg is the principle investigator.

Frequently Asked Questions:

Q: What is the purpose of this study?
A: The Relivion™ device used in this research is an investigational external neurostimulation device, comprised of a headset with integrated electrodes. The electrodes come into contact with your scalp, and when activated, it delivers mild electrical stimulation pulses which are intended to interfere with the migraine episode. The purpose of this research is to evaluate whether the Relivion™ device is safe and helpful in alleviating migraine pain. An earlier study demonstrated positive results.

Q: Am I eligible to participate?
A: To be eligible to participate in this study, you must suffer from migraines with or without Aura and be medically cleared by your doctor to take part in this study

Q: If am eligible and choose to participate, what will be my role in the study?
A: For this study, your study doctor will schedule a minimum of three clinic visits with you and in between those visits, 3 periods of home diary headache reports and treatment with the device, as follows:

  • Screening visit: upon giving written consent to take part in this study, Your medical records will be reviewed by your study doctor and you will undergo a physical and neurological examination. You will be given a migraine diary, which you will be asked to fill in for the next 28 days up until your next study visit.
  • Run-In Period: For approximately 4 weeks, you will be asked to complete a Migraine Diary, you will record migraine episodes timing, duration, intensity, use of anti-pain medications and any additional symptoms such as sensitivity to noise or light and nausea.
  • Randomization visit: You will return to the clinic; the study team will review your diary to confirm you remain eligible for the study. If you are found eligible you will be trained on how to use the study device and how to report study outcomes and be released home with the device and a dedicated iPhone. You will be randomly assigned to one of 2 study groups (you cannot choose your study group; you and the study doctor will not know which group you are in):
    • Group A: active treatment at a therapeutic level.
    • Group B: sham/placebo treatment at a non-therapeutic level.
  • Self-Practice Period: In the next 2 weeks you will be asked to experience the use of the device and diary not during a migraine episode at your home or surrounding. If at least one self-practice run was successful, you will be asked to initiate the ‘Treatment Period’.
  • Treatment Period: during this period, you may use the device at your home for treating a minimum 1 and up to 5 migraine episodes, for up to 10 weeks starting from the randomization visit, whichever comes first.
  • Termination visit: At the end of the Treatment Period, or after completing 5 treatments, you will return to the clinic for the last study visit. At this visit your participation in the study will be over.
    You must make sure that you can come to each visit as scheduled and perform the diary reports and device treatment at home.

Q: Will I be paid for taking part in this research?
A: For taking part in this research, you may be paid up to a total of $350. You will receive the payment after you complete the study visits.

To participate, please call or text the study team at 860.463.2528 or HeadacheResearch@hhchealth.org.

 

 


What's New

Exercise Program

New Twist for Cancer Survivors: Exercise Makes a Difference

So much of cancer seems beyond your control, but staying as active as possible can be key to managing the side effects of the disease and treatment and improving survival. Gretchin Bade, a physical therapist and program director of oncology with the Hartford Hospital Rehabilitation Network, cited at least 20...

Head and Neck Cancer Rehab

Why Head and Neck Cancer Patients Need Speech, Swallow Rehabilitation

By Nicole Silva Speech Language Pathologist Hartford HealthCare Cancer Institute According to the American Cancer Society, head and neck cancer accounts for approximately 65,000 cases annually. In the United States, about 3 percent of all cancers are head and neck cancer . Patients with head and neck cancer often face...

Cancer Navigator

Find Out How Navigators Can Help on Your Cancer Journey

The diagnosis, the appointments, the blood work, the imaging tests – hearing the words “breast cancer” can be overwhelming enough but adding the related tasks can make you shut down emotionally. That’s why Hartford HealthCare Cancer Institute locations offer breast cancer patients the help of nurse navigators who are involved...

Yoga for Cancer

A Healthier You: Cancer Institute Fall Classes, Events

2019 Hartford HealthCare Cancer Institute Fall Calendar Here’s your guide to all of our upcoming fall events: Community Education and Support Programs Bereavement Support Oct. 23,  Nov. 13&27 2- 3:30 pm Hartford HealthCare Cancer Institute at Backus Hospital 326 Washington St., Norwich, Conference Room 2 To register, call 1.855.HHC.HERE (1.855.442.4373)...

Women doing yoga workout at gym

Living With a Cancer Diagnosis as an Older Adult

According to the National Cancer Institute, age is the greatest risk factor for developing cancer. In fact, 60 percent  of people who have cancer are 65 or older. So are 60 percent of cancer survivors. If you are an older adult with cancer, you should know that age is just...

Cancer Survivorship Plan

What Is a Cancer Survivorship Care Plan?

By Deborah Walker, APRN Over a decade ago, the Institute of Medicine recommended every cancer patient receive an individual survivorship care plan that includes guidelines for monitoring and maintaining their health. This recommendation was developed from a prominent report, “From Cancer Patient to Cancer Survivor: Lost in Transition,” which focused...


This Simple Saliva Test Assesses Breast Cancer Risk

By Meghan Burgess Breast cancer has a particularly high prevalence in Connecticut, but a new program is helping women and men identify their risk of developing the disease – and other cancers – through a simple questionnaire and saliva test. The Hereditary Cancer Risk Assessment Program, offered through Hartford HealthCare...